Maggi, Paolo
Ricci, Elena Delfina
Cicalini, Stefania
Pellicanò, Giovanni Francesco
Celesia, Benedetto Maurizio
Vichi, Francesca
Cascio, Antonio
Sarchi, Eleonora
Orofino, Giancarlo
Squillace, Nicola
Madeddu, Giordano
De Socio, Giuseppe Vittorio
Bargiacchi, Olivia
Molteni, Chiara
Masiello, Addolorata
Saracino, Annalisa
Menzaghi, Barbara
Falasca, Katia
Taramasso, Lucia
Di Biagio, Antonio
Bonfanti, Paolo
Article History
Received: 13 December 2022
Accepted: 22 March 2023
First Online: 14 April 2023
Declarations
:
: The SCOLTA Project was conducted in accordance with the Declaration of Helsinki. It was approved by Local Ethics committee L. Sacco Hospital, Milano, Italy, on September 18th, 2002, emended on June 13th, 2013 (protocol no. 352/2013), on December 20th, 2019 (Protocol no. 54085/2019) and on March 3rd, 2020 (Protocol no. 2020/EM/029). All patients included gave their written informed consent to participate in the study.
: Not applicable.
: The following authors served as consultant or advisory board and/or received speaker’s fees and/or received research grants for their institutions, outside the present work: PM and GFP from Gilead Science, ViiV Healthcare, Janssen and Merck Sharp & Dohme. PB from Gilead Science, ViiV Healthcare, Janssen, Merck Sharp & Dohme and Pfizer. ADB from Gilead Science, ViiV Healthcare and Janssen. RB from Gilead Science, ViiV Healthcare, and Merck Sharp & Dohme. AC from Gilead Science, Janssen, Merck Sharp & Dohme; NS from ViiV Healthcare and Janssen; LT from ViiV Healthcare and Gilead Science; GVDS from ViiV Healthcare. All remaining authors have no potential conflicts of interest.